-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HJDTxOqujwXgxAVNa/opa8a8+3IzN7D0M3CZPfNmFtNuAnpIwjopwkZid3DqJdXz
 KTSfyKCmC8yYDFvXr9iszw==

<SEC-DOCUMENT>0001104659-04-028713.txt : 20040928
<SEC-HEADER>0001104659-04-028713.hdr.sgml : 20040928
<ACCEPTANCE-DATETIME>20040928124238
ACCESSION NUMBER:		0001104659-04-028713
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		8
CONFORMED PERIOD OF REPORT:	20040927
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20040928
DATE AS OF CHANGE:		20040928

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DJ ORTHOPEDICS INC
		CENTRAL INDEX KEY:			0001157972
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				330978270
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-16757
		FILM NUMBER:		041049095

	BUSINESS ADDRESS:	
		STREET 1:		2985 SCOTT STREET
		CITY:			VISTA
		STATE:			CA
		ZIP:			92083
		BUSINESS PHONE:		7607271280
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a04-10980_18k.htm
<DESCRIPTION>8-K
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div>

<div style="border:none;border-top:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED
STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES
AND EXCHANGE COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM
8-K</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT
REPORT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt .25in;text-align:center;text-indent:-.25in;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES<br>
EXCHANGE ACT OF 1934</font></b></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt 1.5in;text-align:center;text-indent:-1.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SEPTEMBER
27, 2004</font></b></p>

<p align="center" style="margin:0in 0in .0001pt 1.5in;text-align:center;text-indent:-1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date
of Report (Date of earliest event reported)</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">DJ
ORTHOPEDICS, INC.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of
Registrant as specified in its charter)</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">001-16757</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.14%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">33-0978270</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other
  jurisdiction of<br>
  incorporation)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File
  Number)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer
  Identification<br>
  Number)</font></p>
  </td>
 </tr>
 <tr>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="32%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2985 Scott Street</font></b><font face="Times New Roman"><br>
  <b><font style="font-weight:bold;">Vista, California</font></b></font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:31.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">92083</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="32%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal
  executive offices)</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.14%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="31%" valign="top" style="padding:0in .7pt 0in .7pt;width:31.92%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip Code)</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(800) 336-5690</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone
number, including area code</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">N/A</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former
address, if changed since last report)</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))</p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))</p>

<div style="border:none;border-bottom:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\jkeene\04-10980-1\task190013\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1.01.&#160; Entry into a Material Definitive Agreement.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-family:Times New Roman;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On September 28, 2004, dj Orthopedics, Inc.'s
subsidiary, dj Orthopedics LLC, completed the acquisition of KD Innovation A/S,
one of the Company&#146;s third party distributors in Scandinavia.&#160; In the transaction, which has an effective
date as of August 30, 2004, dj Orthopedics acquired all of the outstanding
stock of the former distributor for a cash payment of $700,000 and an
additional amount up to $500,000 payable over a period of years if financial
goals are met.&#160; The acquired company,
renamed dj Orthopedics Nordic ApS, is headquartered in H</font><font size="2" style="font-size:10.0pt;">&qout;</font><font size="2" style="font-size:10.0pt;">rsholm, near Copenhagen, Denmark and has
direct responsibility for sales, marketing and distribution of dj Orthopedics&#146;
products in Denmark, Finland, Norway and Sweden.&#160; A copy of the stock purchase agreement and a
press release announcing the transaction are filed as Exhibit 10.1 and 99.1,
respectively, to this Current Report.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.02.&#160; Results of Operations and Financial
Condition.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On September 28, 2004, dj Orthopedics, Inc., issued a press release
announcing an update on its expected third quarter financial results and the
integration of its Regentek division.&#160; A
copy of the press release is furnished as Exhibit 99.2 to this Current Report.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 8.01.&#160; Other Events.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On September 28, 2004, dj Orthopedics, Inc., issued a press release
announcing that on September 27, 2004, its board of directors authorized a
program to repurchase stock.&#160; A copy of
the press release containing further details of the program is filed as Exhibit
99.3 to this Current Report.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01. Financial Statements and
Exhibits.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10.0pt;margin:0in 0in .0001pt 29.7pt;text-autospace:none;text-indent:-15.3pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font>Exhibits.</p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="90%" style="border-collapse:collapse;margin-left:31.3pt;width:90.86%;">
 <tr>
  <td width="9%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:9.14%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit No.</font></b></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:88.62%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Document</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock purchase agreement between dj Orthopedics, LLC
  and KD Holdings dated as of August 30, 2004.</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press release dated September 28, 2004 relating to
  dj Orthopedics, Inc.&#146;s acquisition of KD Innovation A/S.</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.2</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press release dated September 28, 2004 relating to
  dj Orthopedics, Inc.&#146;s expected third quarter financial results and Regentek
  integration.</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.14%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.3</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.24%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="88%" valign="top" style="padding:0in .7pt 0in .7pt;width:88.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press release dated September 28, 2004 relating to
  dj Orthopedics, Inc.&#146;s stock repurchase program.</font></p>
  </td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\jkeene\04-10980-1\task190013\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="22%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:22.82%;">
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DJ ORTHOPEDICS, INC.</font></b></p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.7%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="22%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:22.82%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant)</font></p>
  </td>
  <td width="34%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:34.7%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="57%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:57.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="57%" colspan="5" valign="top" style="padding:0in .7pt 0in .7pt;width:57.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.78%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>
  </td>
  <td width="19%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:19.28%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">September 27, 2004</font></p>
  </td>
  <td width="18%" valign="top" style="padding:0in .7pt 0in .7pt;width:18.4%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.8%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.26%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BY:</font></p>
  </td>
  <td width="42%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:42.74%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/
  VICKIE L. CAPPS</font></p>
  </td>
  <td width="6%" valign="top" style="padding:0in .7pt 0in .7pt;width:6.74%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.8%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="53%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:53.74%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vickie
  L. Capps</font></p>
  </td>
 </tr>
 <tr style="page-break-inside:avoid;">
  <td width="42%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:42.46%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in .7pt 0in .7pt;width:3.8%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="53%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:53.74%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senior
  Vice President, Finance and Chief Financial Officer<br>
  (Principal Financial Officer)</font></p>
  </td>
 </tr>
 <tr height="0">
  <td width="36" style="border:none;"></td>
  <td width="144" style="border:none;"></td>
  <td width="138" style="border:none;"></td>
  <td width="28" style="border:none;"></td>
  <td width="32" style="border:none;"></td>
  <td width="110" style="border:none;"></td>
  <td width="209" style="border:none;"></td>
  <td width="50" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\jkeene\04-10980-1\task190013\10980-1-ba.htm',USER='jkeene',CD='Sep 28 11:36 2004' -->


</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a04-10980_1ex10d1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>

<head>



</head>

<body>

<div style="font-family:'Times New Roman';">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
10.1</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">STOCK
PURCHASE AGREEMENT</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Stock
Purchase Agreement (the &#147;Agreement&#148;) is entered into as of August 30, 2004 (the
&#147;Effective Date&#148;), by and between KD Holdings, a Denmark corporation
(&#147;Holdings&#148;), Kirsten Damgaard, an individual and the sole shareholder of
Holdings (&#147;Stockholder&#148;) (Holdings and Stockholder are hereinafter collectively
referred to as &#147;Seller&#148;), and dj Orthopedics, LLC, a Delaware limited liability
company (&#147;Buyer&#148;).</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">R</font></u>  <u>E</u>
<u>C</u>  <u>I</u>  <u>T</u>  <u>A</u>  <u>L</u>  <u>S</u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, Buyer and
Seller have entered into that certain letter agreement dated September 29, 2003
(the &#147;Option&#148;) pursuant to which Seller granted Buyer the option to purchase,
upon terms and conditions set forth therein, all of the outstanding capital
stock in dj Orthopedics Nordic ApS, formerly KD Innovations, (hereinafter, the
&#147;Acquired Business&#148;); and</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, Buyer
wishes to exercise such Option and purchase the capital stock of the Acquired
Business, and Seller wishes to sell such capital stock, all on the terms and
conditions set forth in this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">A</font></u>  <u>G</u>
<u>R</u>  <u>E</u>  <u>E</u>  <u>M</u>  <u>E</u>  <u>N</u>  <u>T</u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, in consideration of the mutual
representations, warranties, covenants and agreements contained herein, the
receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 1</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h1 style="font-weight:normal;margin:0in 0in .0001pt;page-break-after:auto;text-align:center;text-decoration:underline;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">PURCHASE AND SALE OF
STOCK</font></u></h1>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Purchase and Sale of Stock</u>.&#160; Subject to the terms and conditions of this
Agreement and pursuant to the exercise of the Option, Seller does hereby sell,
transfer, convey, assign and deliver to Buyer, and Buyer does hereby purchase,
acquire and accept from Seller, all of Seller&#146;s right, title and interest in
and to the outstanding shares of capital stock of the Acquired Business (the
&#147;Stock&#148;).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transactions on the Effective Date</u>.&#160;&#160; In consideration for the sale, assignment,
transfer and delivery of the Stock, Buyer shall pay Holdings in readily
available funds on the Effective Date pursuant to wire transfer instructions
provided by Seller to Buyer the sum of $700,000 in U.S. dollars (unless
specifically indicated to the contrary, all sums set forth in this Agreement
shall be in U.S. dollar currency).&#160;
Holdings shall deliver to Buyer on the Effective Date the certificates
or other evidence of the Stock, accompanied by such transfer documents as are
necessary under the laws of Denmark to transfer such Stock to Buyer and to
evidence Buyer as the holder of all right, title and interest in the Stock.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='1',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt 4.5pt;text-indent:31.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Additional Scheduled Payments</u>.&#160; As additional consideration, Buyer hereby
agrees to pay Holdings the following amounts subject to the following
conditions:</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 40.5pt;text-indent:31.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Buyer shall make an additional
payment to Holdings on September 1, 2005 in the amount of $125,000 if the
aggregate &#147;net operating income&#148; (as defined below) of the Acquired Business in
the country of Denmark during calendar 2004 and the six-month period ending
June 30, 2005 equals or exceeds the sum of $250,000, and if such net operating
income for the country of Denmark during such period is less than $250,000, then
such payment shall be reduced in proportion to the shortfall in such net
operating income.</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 40.5pt;text-indent:31.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Similarly, Buyer shall make an
additional payment to Holdings on September 1, 2006 in the amount of $125,000
if the aggregate &#147;net operating income&#148; (as defined below) of the Acquired
Business in the country of Denmark during calendar 2005 and the six-month
period ending June 30, 2006 equals or exceeds the sum of $360,000, and if such
net operating income for the country of Denmark during such period is less than
$360,000, then such payment shall be reduced in proportion to the shortfall in
such net operating.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:40.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Possible Additional Consideration</u>.&#160; Buyer hereby agrees to pay Holdings
additional consideration of up to $250,000, at the time and in the manner described
below, if the Acquired Business achieves some or all the following cumulative
net operating income goals as of December 31 of the years shown below:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="41%" style="border-collapse:collapse;margin-left:1.5in;width:41.42%;">
 <tr>
  <td width="55%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.96%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2005</font></p>
  </td>
  <td width="5%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:5.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:32.04%;">
  <p align="right" style="margin:0in 0in .0001pt 10.0pt;text-align:right;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">258,000</font></p>
  </td>
  <td width="3%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.84%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.96%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2006</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.04%;">
  <p align="right" style="margin:0in 0in .0001pt 10.0pt;text-align:right;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">687,000</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="55%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.96%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2007</font></p>
  </td>
  <td width="5%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:5.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:32.04%;">
  <p align="right" style="margin:0in 0in .0001pt 10.0pt;text-align:right;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,303,000</font></p>
  </td>
  <td width="3%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.84%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.96%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2008</font></p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.04%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>
  </td>
  <td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.04%;">
  <p align="right" style="margin:0in 0in .0001pt 10.0pt;text-align:right;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,065,000</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.84%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March 1, 2006 and each subsequent March 1 through March 1, 2009, the
cumulative net operating income of the Acquired Business shall be determined as
of the preceding December 31, and if the applicable goal has been exceeded,
Buyer shall pay Holdings as additional consideration hereunder an amount equal
to 50% of such excess.&#160; Once the
cumulative total of such additional consideration reaches $250,000, no further
such payments will be made.&#160; The failure
of the Acquired Business to reach any applicable goal in a year subsequent to a
year in which the applicable goal was achieved will not affect any of such
additional consideration previously paid for the year in which such applicable
goal was achieved.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Determination
of Net Operating Income</u>.&#160;&#160; For
purposes of sections 1.3 and 1.4 above, &#147;net operating income&#148; shall be
determined by calculating the gross profit of the Acquired Business and
subtracting therefrom selling expenses, marketing expenses, general and
administrative expenses and depreciation.&#160;
In addition, the net operating income figures in sections 1.3 and 1.4
above have been calculated using an exchange rate of 6.5 DKK per US dollar, and
such exchange rate shall be used for purposes of all calculations under
sections 1.3 and 1.4 above.&#160; The
determination of such net operating income for the Acquired Business shall be
made by Buyer.&#160; Following June 30 of
2005 and 2006, Buyer shall, to determine the payment under section 1.3 above,
calculate and report the net</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='2',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">operating income of the Acquired Business in the country of Denmark for
the period required by section 1.3, limiting such calculation for this purpose
to sales achieved in Denmark and expenses incurred in Denmark.&#160; Following December 31 of each year from 2005
to and including 2008, Buyer shall, to determine the payment under section 1.4
above, calculate and report the cumulative net operating income of the Acquired
Business as a whole from January 1, 2005 through each such December 31.&#160; Buyer shall report to Seller each such
calculation, which shall be the basis for any payment of additional
consideration by Buyer under either section 1.3 or 1.4 above.&#160; If Seller disagrees with the determination
of Buyer, the parties agree to meet and discuss any such disagreement in order
to resolve any differences.&#160; If the
disagreement is not resolved to Seller&#146;s satisfaction, Seller shall be entitled
to resolve such disagreement through the dispute resolution procedure in
section 5.4(b) below.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Continued Employment of Stockholder</u>.&#160; Stockholder understands that her continued
employment and active participation in the Acquired Business during the period
of time reflected in section 1.4 above is a material consideration to the
Seller&#146;s participation in the transaction provided for in this Agreement.&#160; Accordingly, if Stockholder voluntarily
terminates her employment with the Acquired Business prior to the completion of
the payment opportunity under section 1.4 above, then Buyer shall have no
further obligation to make any payments under such section.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 2</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND
WARRANTIES<br>
OF THE SELLER</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each of Holdings and the Stockholder represents and warrants, jointly
and severally, to the Buyer as follows:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Organization
and Good Standing</u>.&#160; The Acquired
Business is a corporation duly organized, validly existing and in good standing
under the laws of Denmark.&#160; The Acquired
Business is duly qualified and registered to transact business and is in good
standing in every country and other jurisdiction in which the character and
extent of its business makes such qualification or registration necessary.&#160; The Acquired Business has all necessary
corporate power and authority, including all necessary licenses and permits, to
carry on its business as it is now being conducted, and to own or lease and
operate its properties and assets.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorization
and Approvals</u>.&#160; Holdings has all
requisite corporate power and authority to enter into this Agreement and to
perform its obligations hereunder.&#160; This
Agreement has been duly executed and delivered by the Seller and constitutes
the legal, valid and binding obligation of Seller, enforceable in accordance
with its terms, except as may be limited by bankruptcy, reorganization,
insolvency, moratorium or other laws relating to or affecting the enforcement
of creditors&#146; rights and remedies generally.&#160;
This Agreement has been duly and validly authorized by and approved by
all requisite corporate action on the part of Holdings&#146; Board of Directors and</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='3',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">stockholders.&#160; No further
approvals or consents by, or filings with, any national, regional or other
court or governmental or administrative body, agency or other third party is
required in connection with the execution and delivery by the Seller of this
Agreement, or the consummation by the Seller of the transactions contemplated
hereby.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Equity Structure of the Acquired
Business</u>.&#160; The Stock represents all
of the issued and outstanding capital stock of the Acquired Business and no
other stock or equity interest in the Acquired Business has been issued or is
outstanding.&#160; Except for the Option and
this Agreement, there are no options, warrants, convertible debt or securities,
calls, agreements, arrangements or understandings or other rights of any kind
or character to purchase any equity interest in the Acquired Business or that
would otherwise result in the ownership of any equity interest in the Acquired
Business by any party other than the ownership of the Stock by Holdings.&#160; The equity interest represented by the
Stock, and the Stock itself, has been duly authorized by all necessary
corporate action of the Acquired Business, is validly issued, fully paid and
nonassessable and has been issued in full compliance with all applicable laws
and regulations.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title to Stock</u>.&#160; Holdings is the registered and beneficial
owner of the Stock, free and clear of any liens, encumbrances, security
interests, restrictions or claims whatsoever, with full power and authority to
convey the Stock to Buyer in accordance with the terms of this Agreement.&#160; No other person or party has or can claim
any interest of any kind in the Stock or in any right in respect of the Stock.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No
Conflicts</u>.&#160; Neither the execution
and delivery of this Agreement nor the consummation of the transactions
contemplated hereby will (a) violate any provision of the charter or
organizational documents of the Acquired Business or Holdings, (b) violate, or
be in conflict with, or constitute a default (or other event which, with the
giving of notice or lapse of time or both, would constitute a default) under,
or give rise to any right of termination, cancellation or acceleration under
any of the terms, conditions or provisions of any lease, license, promissory
note, contract, agreement, mortgage, deed of trust or other instrument or
document to which the Acquired Business or the Seller is a party or by which
the Acquired Business or the Seller or any of its or her respective&#160; properties or assets may be bound, (c)
violate any order, writ, injunction, decree, law, statute, rule&nbsp;or
regulation of any court or governmental authority applicable to the Acquired
Business or the Seller or any of its or her respective properties or assets or
(d) give rise to a declaration or imposition of any claim, lien, charge,
security interest or encumbrance of any nature whatsoever upon any of the
assets of the Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Taxes</u>.&#160; The Acquired Business has paid or caused to
be paid within the time and in the manner prescribed by law all national, regional
and local taxes of any type, including without limitation, income, franchise,
gross receipts, sales or property taxes, payable or due from and owed by the
Acquired Business for all periods ending on or prior to the date hereof except
for taxes which are accrued but not yet due and payable.&#160; The Acquired Business has collected all
sales, use and value added taxes required to be collected, and has remitted, or
will remit on a timely basis, such amounts to the appropriate governmental
authorities and has furnished properly completed exemption certificates for all
exempt transactions.&#160; The Acquired
Business has properly withheld income or similar taxes and required social
charges and paid such amounts to the proper</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='4',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">governmental authority with respect to all employees of the Acquired
Business.&#160; None of the assets of the
Acquired Business are subject to any liens in respect of taxes (other than for
current taxes not yet due and payable).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Contracts</u>.&#160; Schedule 2.7 hereto contains a complete,
current and correct list of all material contracts, commitments, obligations or
agreements of the Acquired Business, whether written or oral, formal or
informal (the &#147;Contracts&#148;).&#160; To the
knowledge of the Seller, no event has occurred which would constitute a default
(or any event which, with the giving of notice or lapse of time or both, would
constitute a default) under any term or provision of any of the Contracts and
thereby allow a party thereto to terminate or claim damages therefor.&#160; Each of the Contracts is in full force and
effect and is the legal, valid and binding obligation of the Acquired Business
and, to the knowledge of the Seller, of the other parties thereto, enforceable
in accordance with its terms, except as may be limited by bankruptcy,
reorganization, insolvency, moratorium or other laws relating to or affecting
the enforcement of creditors&#146; rights and remedies generally.&#160; The Acquired Business is not a party to any
Contract that restricts Acquired Business, or will restrict Buyer after the
Effective Date, from carrying on the Acquired Business or any part thereof, or
from competing in any line of business with any person, corporation or entity.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Title
to Assets</u>.&#160; The Acquired Business
has good, valid and marketable title to all of its assets.&#160; All such assets are free and clear of title
defects, liens, claims, charges, pledges, security interests, easements or
other encumbrances of any kind or nature whatsoever, except for liens, taxes
and assessments not yet due and liens arising by law or in the ordinary course
of business that do not materially adversely affect such assets or the
operation of the Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:36.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Financial Statements</u>. Schedule
2.9 contains the balance sheet of the Acquired Business as of August 28, 2004
(the &#147;Balance Sheet&#148;) and the statement of income and expenses of the Acquired
Business for the period from January 1, 2004 to the date of the Balance Sheet
(the &#147;Income Statement&#148; and collectively with the Balance Sheet, the &#147;Financial
Statements&#148;).&#160; The Financial Statements
(i)&nbsp;have been prepared in conformity with generally accepted accounting
principles applicable to companies in the countries is which the Acquired
Business operates consistently applied with prior periods, and (ii) fairly
present the financial condition and results of operations of the Acquired
Business as of the dates and for the periods indicated therein. The Balance
Sheet accurately reflects all liabilities, obligations and commitments of any
nature (whether absolute, accrued, contingent or otherwise and whether matured
or unmatured) of the Acquired Business except (a) liabilities, obligations or
commitments incurred since the date of the Balance Sheet in the ordinary course
of business and consistent with past practice, (b) liabilities or obligations
described on Schedule 2.9 or Schedule 2.12 hereto and (c) other liabilities or
obligations that are not material, individually or in the aggregate, to the
Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Accounts
Receivable</u>.&#160; The Accounts Receivable
shown in the Balance Sheet, subject to changes in the ordinary course of
business from the date of the Balance Sheet to the Effective Date, constitute
all of the accounts receivable of the Acquired Business and represent <u>bona</u>
<u>fide</u> sales actually made or on or prior to such date in the ordinary
course of business of the Acquired Business and consistent with past
practices.&#160; To Seller&#146;s knowledge, there
is no contest, claim or right of</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='5',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">set-off contained in any oral or written agreement with any account
debtor relating to the amount or validity of any such Account Receivable.&#160; The Accounts Receivable are valid and
collectible in the ordinary course of business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.11&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Compliance
With Laws</u>.&#160; To the knowledge of
Seller, Seller has conducted the Acquired Business in compliance with, and is
not in violation of, applicable laws, statutes, ordinances, rules, regulations,
orders and other requirements of all national governmental authorities, and of all
territories, states, municipalities and other political subdivisions and
agencies thereof, having jurisdiction over the Acquired Business, including
without limitation all such laws, regulations, ordinances and requirements
relating to environment, antitrust, consumer protection, labor and employment,
zoning and land use, immigration, health, and occupational safety,&#160; except where the failure to be in compliance
would not have a material adverse effect on the Acquired Business.&#160; The Acquired Business has not received any
written notification of any asserted present or past failure to comply with any
laws, statutes, ordinances, rules, regulations, orders or other legal or
regulatory requirements.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.12&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Litigation</u>.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except
as set forth on Schedule 2.12, there is no pending or, to the best knowledge of
the Seller, threatened action, suit, arbitration proceeding, investigation or
inquiry before any court or governmental or administrative body or agency, or
any private arbitration tribunal, against, relating to or affecting the
Acquired Business, or the transactions contemplated by this Agreement, nor to
the best knowledge of the Seller, are there any facts or circumstances which
could reasonably lead to or provide the basis for any such threatened action, suit,
arbitration proceeding, investigation or inquiry.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; There
is not in effect any order, judgment or decree of any court or governmental or
administrative body or agency enjoining, barring, suspending, prohibiting or
otherwise limiting the Acquired Business or any officer, director or employee
of the Acquired Business from conducting or engaging in any aspect of the
Acquired Business, or requiring Seller or any officer, director or employee of
Seller to take certain action with respect to any aspect of the Acquired
Business.</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The
Acquired Business is not in violation of or in default under any order,
judgment, writ, injunction or decree of any court or governmental or
administrative body or agency.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.13&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Brokers
and Finders</u>.&#160; Seller has not engaged
or authorized any broker, finder, investment banker or other third party to act
on its behalf, directly or indirectly, as a broker, finder, investment banker
or in any other like capacity in connection with this Agreement or the
transactions contemplated hereby, nor has Seller consented to or acquiesced in
anyone so acting.&#160; Seller knows of no
claim for compensation from any such broker, finder, investment banker or other
third party for so acting on behalf of Seller or any basis for such a claim.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='6',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.14&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Absence of Certain Changes</u>.&#160; </font>&#160;Since the date of the Balance Sheet, the
Acquired Business has been conducted in the ordinary course consistent with
past practice and, to the knowledge of Seller, there has not been:</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any event, occurrence or development
of a state of circumstances or facts relating to the Acquired Business which,
individually or in the aggregate, has had or could reasonably be expected to
have a material adverse effect thereon;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any sale, lease, license or other
disposition of any assets or properties of the Acquired Business, other than in
the ordinary course of business consistent with past practices;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any creation or assumption by the
Acquired Business of any lien, encumbrance or other charge on any of the assets
or properties of the Acquired Business;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any indebtedness for borrowed money
incurred by the Acquired Business or any commitment to incur indebtedness for
borrowed money entered into by the Acquired Business;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the incurrence by the Acquired
Business of any material liability or obligation not in the ordinary course of
business and consistent with past practice;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the entering into a material
contract or any amendment, modification or termination of any Contract listed
on Schedule 2.7 other that the expiration of any such Contract by its terms;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the addition or loss of any employee
of the Acquired Business, or any material increase in, or commitment to
increase, the direct or indirect compensation payable or to become payable to
any employee of the Acquired Business, or the commitment to make severance,
bonus or special payments to any such employee;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any material condemnation, seizure,
damage, destruction or other casualty loss (whether or not covered by insurance)
affecting any of the assets or properties of the Acquired Business; or</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any notice of default or any other
claim, allegation or other assertion that the Acquired Business has been or
will be in breach or violation of any provision of any contract, agreement or
instrument to which it is a party and by which its assets are bound.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 3</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND
WARRANTIES<br>
OF BUYER</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Buyer represents
and warrants to the Seller as follows:</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='7',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Organization
and Power</u>.&#160; Buyer is a limited
liability company duly organized, validly existing and in good standing under
the laws of the State of Delaware, and has all requisite corporate power and
authority to own, lease and operate its properties, and to carry on its
business, as such is now being conducted.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorization
and Enforceability of Agreements</u>.&#160;
Buyer has all requisite corporate power and authority to enter into this
Agreement and to perform its obligations hereunder.&#160; This Agreement has been duly executed and delivered by Buyer and
constitutes the legal, valid and binding obligation of Buyer, enforceable in
accordance with its terms, except as may be limited by bankruptcy,
reorganization, insolvency, moratorium or other laws relating to or affecting
the enforcement of creditors&#146; rights and remedies generally.&#160; This Agreement been duly and validly
authorized by and approved by all requisite corporate action on the part of
Buyer.&#160; No further approvals or consents
by, or filings with, any federal, state, municipal, foreign or other court or
governmental or administrative body, agency or other third party is required in
connection with the execution and delivery by Buyer of this Agreement or the
consummation by Buyer of the transactions contemplated hereby.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No
Conflicts</u>.&#160; Neither the execution
and delivery of this Agreement, nor the consummation of the transactions
contemplated hereby will (a) violate any provisions of the charter or Bylaws of
Buyer, (b) violate, or be in conflict with, or constitute a default (or other
event which, with the giving of notice or lapse of time or both, would
constitute a default) under, or give rise to any right of termination,
cancellation or acceleration under any of the terms, conditions or provisions
of any material lease, license, promissory note, contract, agreement, mortgage,
deed of trust or other instrument or document to which Buyer is a party or by
which Buyer or any of its properties or assets may be bound, (c) violate any
order, writ, injunction, decree, law, statute, rule or regulation of any court
or governmental authority applicable to Buyer or any of its properties or
assets or (d) give rise to a declaration or imposition of any claim, lien,
charge, security interest or encumbrance of any nature whatsoever upon any of
the assets of Buyer&#146;s businesses.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Brokers
and Finders</u>.&#160; Buyer has not engaged
or authorized any broker, finder, investment banker or other third party to act
on behalf of Buyer, directly or indirectly, as a broker, finder, investment
banker or in any other like capacity in connection with this Agreement or the
transactions contemplated hereby, or consented to or acquiesced in anyone so
acting, and Buyer does not know of any claim for compensation from any such
broker, finder, investment banker or other third party for so acting on behalf
of Buyer or of any basis for such a claim.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='8',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 4</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">CERTAIN OTHER COVENANTS
AND AGREEMENTS</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Consents and Filings</u> Each
party shall use all commercially reasonable efforts to obtain or make, as the
case may be, as soon as possible, all filings and requests for governmental
approvals as may be required to be obtained or made by it in order to enable
such party to perform its obligations under this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Delivery of Books and Records</u>.&#160; At the Closing, Seller will deliver to Buyer
all original contracts, books and records of the Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cooperation and Further Assurance</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; After the Closing, the parties
shall cooperate in good faith to facilitate the transfer of the Stock in the
manner contemplated hereunder with minimum disruption for the parties. Each
party shall execute such further documents and instruments as the other may
reasonably request to reflect the transactions contemplated hereunder and to
vest in Buyer full title to the Stock and the Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transfer Taxes</u>.&#160; All sales, use, transfer, stamp, conveyance,
or other similar taxes, duties, excises or governmental charges imposed by any
governmental authority, domestic or foreign, with respect to the sale or
transfer of the Stock shall be borne entirely by Seller.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Transaction Expenses</u>.&#160; Each party shall pay its own expenses
incident to preparing for, entering into and carrying out this Agreement and
the transactions contemplated hereby, whether or not the Closing occurs.&#160; Any such expenses of the Seller shall not be
charged to or incurred by the Acquired Business.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Non-compete</u>.&#160; In consideration of the purchase price paid
by Buyer hereunder and the other covenants and agreements contained herein,
Seller hereby agrees, during the time in which any payment may be due and
payable under either section 1.3 or section 1.4 of this Agreement and for a
period of three (3) years thereafter, that neither Stockholder, Holdings nor
any of its or her successors or assigns, shall compete, directly or indirectly,
with the Buyer, or any affiliate of the Buyer, in any business activity related
to the Acquired Business within the countries of Denmark, Norway, Sweden or
Finland.&#160; For purposes of this section,
Seller&#146;s activity in disposing of existing inventory of Sports Enterprises
shall not be considered to be activities in competition with Buyer or the
Acquired Business.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 5</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">INDEMNIFICATION</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnity
by the Seller</u>.&#160; The Seller shall
indemnify and hold harmless, Buyer and the officers, directors, agents,
affiliates and representatives of Buyer or any of them (the &#147;Buyer</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='9',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnitees&#148;) from and against, and shall reimburse the Buyer
Indemnitees for any loss, liability, damage or expense, including reasonable
attorneys&#146; fees and costs of investigation incurred as a result thereof, that
the Buyer Indemnitees shall incur or suffer (collectively &#147;Buyer&#146;s Recoverable
Losses&#148;), arising out of or resulting from (a) a breach or default by Seller of
or under (i) any representation or warranty contained in <u>Article 2</u>
hereof; or (ii) any agreement or covenant under or pursuant to this Agreement;
or (b) any liability or obligation of the Acquired Business arising or incurred
on or prior to the Effective Date and not disclosed to Buyer under this
Agreement..</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Indemnity
by Buyer</u>.&#160; Buyer shall indemnify and
hold harmless the Seller and the officers, directors, agents, affiliates and
representatives of Seller or any of them (the &#147;Seller Indemnitees&#148;) from and
against, and shall reimburse the Seller Indemnitees for any loss, liability,
damage or expense, including reasonable attorneys&#146; fees and cost of
investigation incurred as a result thereof, that the Seller Indemnities shall
incur or suffer (collectively, &#147;Seller&#146;s Recoverable Losses&#148;) resulting from
(a) a breach or default by Buyer of or under (i) any representation or warranty
contained in <u>Article 3</u> hereof; or (ii) any agreement or covenant under
or pursuant to this Agreement;&#160; or (b)
any liability or obligation of the Acquired Business arising or incurred after
the Effective Date or arising or incurred on or prior to the Effective Date and
disclosed to Buyer under this Agreement..</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitations
on Liability; Offset</u>.&#160; Seller shall
have no liability to Buyer under Section 5.1 above until the aggregate of the
Buyer&#146;s Recoverable Losses reaches $25,000, at which point Seller shall be
liable for all of Buyer&#146;s Recoverable Losses to the extent provided in Section
5.1.&#160; Seller shall not be obligated for
Buyer&#146;s Recoverable Losses under section 5.1(a) above to the extent such losses
exceed the sum of $700,000 plus all amounts paid or payable under sections 1.3
or 1.4 above, nor shall Seller be liable for any claims described in Section
5.1(a) above which are first asserted after August 30, 2005, it being
understood that claims made on or prior to such expiration date shall survive
such expiration date&#160; In the event that
Buyer shall incur a loss that is a Buyer Recoverable Loss at a time in which
any amounts remain to be paid under sections 1.3 or 1.4 above, Buyer may
satisfy Seller&#146;s liability for such loss by reducing the amount of any such
payment or payments under said sections in the amount of such loss.&#160; If Seller disputes its or her liability for
such loss, Seller may submit such dispute to the dispute resolution procedure
described below in section 5.4.</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:-31.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Claims
for Indemnification; Disputes</u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Claims for Indemnification</u>.&#160; Any party hereto shall give Seller or Buyer,
as the case may be (the &#147;Indemnitor&#148;), written notice (the &#147;Claim Notice&#148;) of
any claim (including the receipt of any demand) or the commencement of any
action with respect to which indemnity may be sought (the &#147;Claim&#148; or the
&#147;Claims).&#160; The Claim Notice shall state
(i)&nbsp;the aggregate amount of Buyer&#146;s Recoverable Losses or Seller&#146;s
Recoverable Losses (in either case, &#147;Recoverable Losses&#148;) as to which indemnification
is being sought (which amount may be estimated and updated from time to time),
(ii)&nbsp;the components of the amount of Recoverable Losses for which
indemnification is being sought (which components may be estimated and updated
from time to time); and (iii)&nbsp;the specific grounds upon which the Claim
for indemnification is being made.&#160; The
right to indemnification for a Claim shall be deemed to be accepted by the
Indemnitor unless, within 30 days after the Indemnitor&#146;s receipt of the Claim</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='10',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notice, the Indemnitor shall notify the claimant in writing that it
objects to the right to indemnification with respect to the Claim.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Resolution
of Disputes</u>.&#160; The parties shall
undertake in good faith to have their representatives promptly meet and attempt
to resolve all disputes regarding indemnification.&#160; If the parties are unable to resolve such disputes within 30
days, the resolution of the disputes shall be referred to and settled by
arbitration in accordance with the Rules of Procedure of the Danish Institute
of Arbitration (Copenhagen Arbitration).&#160;
The arbitration tribunal shall be composed of three artibrators.&#160; Each party shall appoint one arbitrator and
the Institute shall appoint a third arbitrator who shall be the chairman of the
arbitration tribunal.&#160; If a party has
not appointed an arbitrator within 30 days of having requested or received
notice of the arbitration, the Institute shall appoint such arbitrator.&#160; The arbitrators in such a proceeding shall
have the authority to resolve any such dispute and award judgments for monetary
amounts, but shall not have the authority to award damages in the nature of
punitive, exemplary or consequential damages.&#160;
The arbitration shall be conducted in English.&#160; Judgment upon the award may be entered in any court of competent
jurisdiction or application may be made to such court for a judicial acceptance
of the award and an order of enforcement, as the case may be.&#160; The successful or prevailing party shall be
entitled to recover all attorneys&#146; fees, expert witness fees and other costs
incurred in such action, in addition to any other relief to which it may be
entitled.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE 6</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">GENERAL PROVISIONS</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Entire
Agreement; Modifications; Waiver</u>.&#160;
Subject to the following sentence, this Agreement and the agreements
ancillary hereto, supersede any and all agreements heretofore made, written or
oral, relating to the subject matter hereof, and constitute the entire
agreement of the parties relating to the subject matter hereof.&#160; This Agreement supersedes the September 29,
2003 option letter between Seller and Buyer except for the cost sharing
provisions of paragraph 1 of said letter, which provisions shall remain in
effect until all such costs for the period specified therein have been
calculated and reimbursed by Buyer as provided in said paragraph 1. This
Agreement may be amended only by an instrument in writing signed by Buyer and
Seller.&#160; Inspection of documents or the
receipt of information pursuant to this Agreement shall not constitute a waiver
of any representation, warranty, covenant or condition hereunder.&#160; No waiver shall be binding unless executed
in writing by the party making such waiver.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>.&#160; If any clause or provision of this Agreement
shall be held invalid or unenforceable by the final determination of a court of
competent jurisdiction, and all appeals therefrom shall have failed or the time
for such appeals shall have expired, such clause or provision shall be deemed
eliminated from this Agreement but the remaining provisions shall nevertheless
be given full force and effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors
and Assigns</u>.&#160; Neither party hereto
may assign or transfer all or a portion of its rights or obligations under this
Agreement without the prior written consent of the other party.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='11',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Subject to the foregoing, this Agreement shall be binding upon and
inure to the benefit of each of the parties hereto, and their respective
successors and assigns.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Counterparts</u>.&#160; This Agreement may be executed in several
counterparts, each of which shall be deemed an original, and all of which
together shall constitute one and the same instrument.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Governing
Law</u>.&#160; This Agreement shall be
construed and interpreted in accordance with the internal substantive laws of
the Country of Denmark.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Notices</u>.&#160; All notices required or desired to be given
hereunder shall be given in writing and signed by the party so giving notice,
and shall be effective when personally delivered or sent by facsimile with
receipt confirmed or two business days after transmission if sent by overnight
delivery service and appropriate confirmation is received, addressed as set
forth below.&#160; Any party from time to
time may change such party&#146;s address for giving notice by giving notice thereof
in the manner outlined above:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to Buyer:</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics, LLC</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2985 Scott Street</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vista, California&#160;
  92083</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Donald M. Roberts</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile:</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(760) 734-3536</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If to the Seller:</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">KD Holdings</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:</font></p>
  </td>
  <td width="62%" valign="top" style="padding:0in 0in 0in 0in;width:62.86%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kirsten Damgaard</font></p>
  </td>
 </tr>
 <tr>
  <td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.82%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
  <td width="74%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:74.18%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile:</font></p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Recitals,
Schedules and Exhibits</u>.&#160; The
recitals, schedules and exhibits to this Agreement are incorporated herein and,
by this reference, made a part hereof as if fully set forth at length herein.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the date first above written.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='12',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DJ ORTHOPEDICS, LLC</font></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="31%" colspan="9" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:31.64%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:5.9%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="25%" colspan="6" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:25.74%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.88%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>
  </td>
  <td width="26%" colspan="8" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:26.76%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="21%" colspan="6" valign="top" style="padding:0in 0in 0in 0in;width:21.56%;">
  <p align="center" style="margin:0in 0in .0001pt 30.0pt;text-align:center;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;Buyer&#148;</font></p>
  </td>
  <td width="21%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:21.56%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 60.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">KD HOLDINGS</font></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="31%" colspan="9" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:31.64%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="6%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:6.04%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>
  </td>
  <td width="25%" colspan="5" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:25.6%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:5.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>
  </td>
  <td width="26%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:26.58%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.96%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="37%" colspan="9" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in 0in 0in 0in;width:37.0%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="6%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:6.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="25%" colspan="8" valign="top" style="padding:0in 0in 0in 0in;width:25.96%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kirsten Damgaard</font></p>
  </td>
  <td width="17%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:17.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="32%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:32.52%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" colspan="11" valign="top" style="padding:0in 0in 0in 0in;width:43.12%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.36%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="17%" valign="top" style="padding:0in 0in 0in 0in;width:17.94%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.58%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="23%" colspan="7" valign="top" style="padding:0in 0in 0in 0in;width:23.04%;">
  <p align="center" style="margin:0in 0in .0001pt 30.0pt;text-align:center;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;Seller&#148;</font></p>
  </td>
  <td width="20%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:20.08%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
 </tr>
 <tr height="0">
  <td width="176" style="border:none;"></td>
  <td width="129" style="border:none;"></td>
  <td width="105" style="border:none;"></td>
  <td width="40" style="border:none;"></td>
  <td width="35" style="border:none;"></td>
  <td width="1" style="border:none;"></td>
  <td width="6" style="border:none;"></td>
  <td width="1" style="border:none;"></td>
  <td width="72" style="border:none;"></td>
  <td width="11" style="border:none;"></td>
  <td width="21" style="border:none;"></td>
  <td width="80" style="border:none;"></td>
  <td width="1" style="border:none;"></td>
  <td width="43" style="border:none;"></td>
 </tr>
</table>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

</div>


<!-- SEQ.=1,FOLIO='13',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-ka.htm',USER='mrnathan',CD='Sep 28 05:34 2004' -->
</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>a04-10980_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>

<head>



</head>

<body link="blue" vlink="purple">

<div style="font-family:'Times New Roman';">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
99.1</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="113" height="51" src="g109801mmimage002.jpg"></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Company Investor/ Media Contact:</font></u></b></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics, Inc.</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mark Francois</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director of Investor
  Relations</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(760) 734-4766</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.djortho.com</font></p>
  </td>
  <td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
  <p align="center" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h5 align="left" style="margin:0in 0in .0001pt;page-break-after:auto;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">FOR IMMEDIATE RELEASE</font></u></b></h5>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h3 align="center" style="margin:0in 0in .0001pt;page-break-after:auto;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">DJ ORTHOPEDICS EXPANDS
INTERNATIONAL STRATEGY WITH ACQUISITION<br>
OF DISTRIBUTOR IN SCANDINAVIA</font></b></h3>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SAN
DIEGO, CA, September 28, 2004<i><font style="font-style:italic;"> &#150;</font></i>  </font></b>dj Orthopedics, Inc.,
(NYSE: DJO), a global medical device company specializing in rehabilitation and
regeneration products for the non-operative orthopedic and spine markets, today
announced that it has acquired KD Innovation A/S, one of the Company&#146;s third
party distributors in Scandinavia, to provide direct distribution of its
products to the Nordic countries. The acquired company, renamed dj Orthopedics
Nordic ApS, is headquartered in H&#248;rsholm,
near Copenhagen, Denmark and, effective September 2004, has direct
responsibility for sales, marketing and distribution of dj Orthopedics&#146;
products in Denmark, Finland, Norway and Sweden.</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics initiated its direct distribution strategy in major
international markets in early 2002, forming subsidiaries in Germany, the
United Kingdom and Canada, adding France in late 2003.&#160; Currently, the Company sells its products,
primarily rigid knee braces and soft goods, in over 35 foreign countries
including most European countries, Canada, Australia and Japan.&#160; International net revenues comprised 12
percent of total consolidated net revenues in the first six months of fiscal
2004.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We have made significant progress with our international growth
strategy, building a portfolio of direct selling subsidiaries in key
international markets. Direct presence in these markets provides us with better
access to our customer base and better control of our marketing programs, as
well as higher revenues and gross margins by capturing the in-market
distributor&#146;s margin on sales of our products,&#148; said Les Cross, president and
CEO of dj Orthopedics.&#160; &#147;With the
acquisition of our strongest Scandanavian distributor, we now have the
opportunity to broaden our reach throughout the Nordic region.&#148;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">-more-</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In three separate press
releases today, dj Orthopedics also announced that:</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company provided an update on its
expectations for the third quarter financial results and Regentek<sup>TM</sup>
integration.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Company&#146;s Board of Directors has authorized a $20 million stock repurchase
program.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company&#146;s Mexico facility was named as
one of <i><font style="font-style:italic;">IndustryWeek&#146;s</font></i> ten best
manufacturing plants in North America.&#160;
The release also updated the Company&#146;s progress on its new manufacturing
facility in Mexico.&#160; In the release dj
Orthopedics announced that it will host an investor day at the new
manufacturing facility on November 30, 2004.</p>

<p style="margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conference Call Information</font></b></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj
Orthopedics has scheduled an investor conference call to discuss today&#146;s
announcements beginning at 10:00 AM, Pacific Time, 1:00 PM Eastern Time, today,
September 28, 2004.&#160; Individuals
interested in listening to the conference call may do so by dialing (706)
634-0177, using the reservation code 1133883.&#160;
A telephone replay will be available for 48 hours following the
conclusion of the call by dialing (706) 645-9291 and using the above
reservation code.&#160; The live conference
call also will be available via the Internet at www.djortho.com, and a
recording of the call will be available on the Company&#146;s website.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About dj Orthopedics, Inc.</font></b></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics is a global medical device company
specializing in rehabilitation and regeneration products for the non-operative
orthopedic and spine markets.&#160; The
Company&#146;s broad range of over 600 rehabilitation products, including rigid knee
braces, soft goods and pain management products, are used in the prevention of
injury, in the treatment of chronic conditions and for recovery after surgery
or injury.&#160; The Company&#146;s regeneration
products consist of bone growth stimulation devices that are used to treat
nonunion fractures and as an adjunct therapy after spinal fusion surgery.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company sells its products in the United States and in more than 35
other countries through networks of agents, distributors and its direct sales
force that market its products to orthopedic and podiatric surgeons, spine
surgeons, orthopedic and prosthetic centers, third-party distributors,
hospitals, surgery centers, physical therapists, athletic trainers and other
healthcare professionals.&#160; For
additional information on the Company, please visit www.djortho.com</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Safe Harbor Statement</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This press release
contains forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934.&#160; Such statements relate to, among
other </font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">things, increases in
revenues and gross margins as a result of maintaining a direct presence in
international markets including the Nordic countries as a result of the
acquisition.&#160; The words &#147;believe,&#148;
&#147;should,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;estimate&#148; and &#147;anticipate,&#148; variations of such
words and similar expressions identify forward-looking statements, but their
absence does not mean that a statement is not a forward-looking statement.&#160; Forward-looking statements are based on the
Company&#146;s current expectations and are subject to a number of risks,
uncertainties and assumptions. The Company&nbsp;undertakes no obligation to update
any forward-looking statements, whether as a result of new information, future
events or otherwise.&nbsp; Among the important factors that could cause actual
results to differ significantly from those expressed or implied by such
forward-looking statements are risks relating to the successful implementation
of our international business strategy including our transition to direct
distribution of our products in select foreign countries; the continued growth
of our markets; the success of our manufacturing initiatives; product
development and/or product licensing and timely product introductions; our
dependence on orthopedic professionals, agents and distributors for marketing
our products; the restrictions imposed by the terms of our indebtedness;
government regulations; developing and protecting our intellectual property;
and the effects of healthcare reform, managed care and buying groups on prices
of our products.&#160; Other risk factors are
detailed in our Annual Report on Form 10-K
for the 2003 calendar year, filed on March 12, 2004 with the Securities and
Exchange Commission.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

</div>


<!-- SEQ.=1,FOLIO='',FILE='C:\jms\mramana\04-10980-1\task189510\10980-1-mm.htm',USER='mrnathan',CD='Sep 28 05:27 2004' -->
</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>a04-10980_1ex99d2.htm
<DESCRIPTION>EX-99.2
<TEXT>
<html>

<head>





</head>

<body lang="EN-US" link="blue" vlink="purple">

<div>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.2</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="105" height="47" src="g109801noimage002.jpg"></font></p>

<table border="0" cellspacing="0" cellpadding="0" width="47%" style="border-collapse:collapse;width:47.12%;">
 <tr>
  <td width="294" valign="top" style="padding:0in 0in 0in 0in;width:220.5pt;">
  <p align="left" style="font-style:italic;font-weight:bold;margin:0in 0in .0001pt;page-break-after:avoid;text-align:left;"><b><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:normal;">Company
  Investor/ Media Contact:</font></u></i></b></p>
  </td>
 </tr>
 <tr>
  <td width="294" valign="top" style="padding:0in 0in 0in 0in;width:220.5pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics, Inc.</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" valign="top" style="padding:0in 0in 0in 0in;width:220.5pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mark Francois<br>
  Director of Investor Relations</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" valign="top" style="padding:0in 0in 0in 0in;width:220.5pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(760) 734-4766</font></p>
  </td>
 </tr>
 <tr>
  <td width="294" valign="top" style="padding:0in 0in 0in 0in;width:220.5pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">mark.francois@djortho.com</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="margin:0in 0in .0001pt;text-align:left;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FOR
IMMEDIATE RELEASE</font></u></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">DJ
ORTHOPEDICS PROVIDES UPDATE ON EXPECTATIONS FOR THIRD QUARTER FINANCIAL RESULTS
AND REGENTEK INTEGRATION</font></b></p>

<p align="center" style="font-family:Times New Roman;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&#151;</font></b><font size="2" style="font-size:10.0pt;">Conference Call and Live Webcast to be
held at 1:00 PM Eastern Time Today&#151;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SAN
DIEGO, CA, September 28, 2004<i><font style="font-style:italic;"> &#151;</font></i>  </font></b><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj
Orthopedics, Inc., (NYSE: DJO), a global medical device company specializing in
rehabilitation and regeneration products for the non-operative orthopedic and
spine markets, today provided an update on the Company&#146;s expected third quarter
financial results and the integration of its Regentek<sup> TM</sup> division</font><font size="2" face="Times New Roman" style="font-size:10.0pt;">.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj
Orthopedics announced its Regentek integration strategy on July 27, 2004, with
the intention of driving stronger sales growth and profitability for the
Regentek segment beginning in 2005.&#160; dj
Orthopedics announced today that the integration activities are progressing in
line with the Company&#146;s expectations.&#160;
The integration is comprised of the integration of the Regentek OL1000<sup>TM</sup>
sales force into the Company&#146;s DonJoy&#174; sales channel, as well as the relocation
of the Regentek business operations from Tempe, Arizona to dj Orthopedics&#146;
headquarters in Vista, California.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company announced today that it
expects to report third quarter revenue of approximately&#160; $62.5 million, or approximately two percent
below its original expected range of $63.5 million to $65.5 million. The Company
also confirmed that the short-term impact from the integration of the Regentek
sales force on its third quarter Regentek OL1000 revenues was in line with its
expectations.&#160; Additionally, although not
affected by the integration, sales of the Regentek SpinaLogic&#174; product fell
short of the Company&#146;s expectations. As a result, the Company expects to report
total Regentek revenues of about six percent less than pro forma revenues for
the third quarter of 2003.</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">With respect to its core rehabilitation
business segments, DonJoy&#174;, ProCare&#174;, OfficeCare&#174; and International, the
Company indicated that it enjoyed a strong quarter for athletic-related sales
and sales of its osteoarthritic knee braces and, accordingly, expects to report
growth for rigid knee bracing products of </font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\cmuller\04-10980-1\task189642\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">approximately eight percent for the
quarter. The Company also expects to report growth of approximately 18 percent
in its International segment for the third quarter. However, the Company also
experienced an impact from recent changes in the California workers&#146; compensation
system, which contributed to a decrease in third quarter revenue from customers
in California of approximately $0.6 million, compared to the third quarter of
2003. The Company also had lower than expected patient volume in its OfficeCare
segment, and expects growth in this segment to be less than one percent for the
third quarter.&#160; In the aggregate, the
Company expects its rehabilitation revenues for the third quarter to be about
$0.5 million less than original expectations.</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a direct result of the lower Regentek
revenues, the Company anticipates reporting lower gross margins and operating
margins in the third quarter than those achieved in the second quarter of 2004.
Operating margins are expected to be between 15 percent and 17 percent of net
revenues, before the impact of approximately $2 million of certain one-time
charges related to the Regentek integration. Excluding the impact of the
integration charges, which are expected to reduce reported earnings per share
by approximately $0.05, the Company anticipates earnings per share for the
third quarter to be between $0.23 and $0.24. Reported earnings per share are
expected to be between $0.18 and $0.19. The Company expects operating cash flow
for the quarter to be over $10 million.</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We remain confident that integrating the
Regentek and DonJoy sales forces is the correct strategy for dj
Orthopedics.&#160; Greater sales depth across
the U.S. from one of the strongest distribution channels in non-operative
orthopedics should enable us to grow faster than the market in 2005,&#148; said Les
Cross, president and CEO of dj Orthopedics.&#160;
&#147;Overall, the integration is proceeding according to plan.&#160; Training of our DonJoy sales force is nearly
complete and has been received with great enthusiasm.&#160; Additionally, feedback from the field
suggests that the DonJoy channel is beginning to achieve success with new
prescriptions, the result of leveraging our DonJoy relationships with many
orthopedic surgeons that the separate Regentek sales force was unable to reach.&#160; We have committed recruiting resources to
assist our DonJoy distribution partners with the hiring of new Regentek
specialists, and we have already added several new specialists.&#160; As expected, we have also experienced a
modest amount of turnover within the existing Regentek sales force and as
anticipated, we have seen some disruption in Regentek OL1000 revenues during
the third quarter.&#160; We remain confident
that this will be a short-term impact and that we will begin to see revenue
upside from the integration during the fourth quarter and on into 2005. We
believe that our SpinaLogic sales were impacted by unusually slow market
conditions during the quarter. We are working closely with our selling partner,
DePuy Spine, to better understand the current market trends in this segment and
to optimize our selling strategy. We believe we have the best electrical bone
growth stimulation technology in the industry and are </font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">more</font></p>

<div align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\cmuller\04-10980-1\task189642\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">well positioned to grow faster than our
competitors and increase our share in both segments of this important market.&#148;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The relocation of the Regentek operations
and administrative functions from Tempe, Arizona to dj Orthopedics&#146; Vista,
California headquarters is expected to provide the Company with cost savings
opportunities based on synergies in headcount and facilities.&#160; This component of the integration is expected
to save the Company approximately $3 million in net annual pre-tax operating
expenses, beginning in 2005. The Company indicated that this component of the
integration is proceeding on schedule to be completed before year end, and that
it has successfully filled approximately 65 percent of the positions required
to be added to its Vista location to support the Regentek business activities.
The Company previously announced that it expects to incur one-time charges
related to the integration of $4 million to $5 million in the second half of
2004.</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In conclusion, Mr. Cross said, &#147;Although
we are disappointed by the slight revenue shortfall expected for the third
quarter, we believe we have accomplished several important milestones in our
business thus far in 2004, including the introduction of several important new
products, the expansion of our manufacturing facilities in Mexico, the
repayment of debt, reducing our annual interest expense by over $10 million,
and perhaps most importantly, the soon to be completed integration of our
Regentek business.&#160; With the completion
of the integration by the end of 2004 as planned, and with clear competitive
product advantages, one of the largest and most productive distribution
channels in our industry and a world-class operations team driving continuous
improvement in our costs of operations and our customer service, we anticipate
a strong 2005, with significant earnings growth over 2004, demonstrating the
quality and earnings potential of dj Orthopedics. We will provide updated
expectations for the fourth quarter of 2004 when we release our full third
quarter earnings, but we are currently targeting a revenue range of $65 million
to $68 million for the fourth quarter.&#148;</font></p>

<p align="left" style="line-height:normal;margin:0in 0in .0001pt;text-align:left;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In three separate press releases today, dj Orthopedics also announced
that:</font></p>

<p style="font-family:Times New Roman;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company&#146;s Board of
Directors has authorized a $20 million stock repurchase program.</font></p>

<p style="font-family:Times New Roman;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company&#146;s Mexico
facility was named as one of <i><font style="font-style:italic;">IndustryWeek&#146;s</font></i>
ten best manufacturing plants in North America.&#160;
The release also updated the Company&#146;s progress on its new manufacturing
facility in Mexico.&#160; In the release dj
Orthopedics announced that it will host an investor day at the new
manufacturing facility on November 30, 2004.</font></p>

<p style="font-family:Times New Roman;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Company has expanded its international
strategy with the acquisition of its largest distributor in Scandinavia.</font></p>

<p style="margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\cmuller\04-10980-1\task189642\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' -->
<br clear="all" style="page-break-before:always;">


<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conference Call Information</font></b></p>

<p style="font-family:Times New Roman;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics has
scheduled an investor conference call to discuss today&#146;s announcements beginning
at 10:00 AM, Pacific Time, 1:00 PM Eastern Time, today, September 28,
2004.&#160; Individuals interested in
listening to the conference call may do so by dialing (706) 634-0177, using the
reservation code 1133883.&#160; A telephone
replay will be available for 48 hours following the conclusion of the call by
dialing (706) 645-9291 and using the above reservation code.&#160; The live conference call also will be
available via the Internet at www.djortho.com, and a recording of the call will
be available on the Company&#146;s website. </font><font size="2" style="font-size:10.0pt;">dj Orthopedics intends to
release full third quarter 2004 financial results on October 26, 2004.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">UBS Global Life Sciences Conference</font></b></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics is scheduled to make a presentation to investors at the
UBS Global Life Sciences Conference in New York City on September 30, 2004 at
10:00 AM Eastern time.&#160; Interested
investors may listen to the presentation live via webcast by visiting the UBS
website at <u>www.ibb.ubs.com</u> and clicking on the &#147;Conferences&#148; box in the
middle of the page, then follow the link for &#147;Webcast&#148; under the Global Life
Sciences Conference heading.&#160; The webcast
will be archived beginning three hours after the live event and continue until
October 30, 2004.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About
dj Orthopedics, Inc.</font></b></p>

<p style="margin:0in 0in 12.0pt;text-autospace:none;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics is a global medical device company
specializing in rehabilitation and regeneration products for the non-operative
orthopedic and spine markets.&#160; The
Company&#146;s broad range of over 600 rehabilitation products, including rigid knee
braces, soft goods and pain management products, are used in the prevention of
injury, in the treatment of chronic conditions and for recovery after surgery
or injury.&#160; The Company&#146;s regeneration
products consist of bone growth stimulation devices that are used to treat
nonunion fractures and as an adjunct therapy after spinal fusion surgery.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
Company sells its products in the United States and in more than 35 other
countries through networks of agents, distributors and its direct sales force
that market its products to orthopedic and podiatric surgeons, spine surgeons,
orthopedic and prosthetic centers, third-party distributors, hospitals, surgery
centers, physical therapists, athletic trainers and other healthcare
professionals.&#160; For additional
information on the Company, please visit www.djortho.com.</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>


<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\cmuller\04-10980-1\task189642\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' -->
<br clear="all" style="page-break-before:always;">


<p style="line-height:normal;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Safe Harbor Statement</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934.&#160; Such
statements relate to, among other things, the Company&#146;s future growth and
profitability, growth strategy, Regentek integration strategy and the Company&#146;s
anticipated financial results for the third and fourth quarters of 2004 and for
2005.&#160; The words &#147;believe,&#148; &#147;should,&#148; &#147;expect,&#148;
&#147;intend,&#148; &#147;estimate&#148; and &#147;anticipate,&#148; variations of such words and similar
expressions identify forward-looking statements, but their absence does not
mean that a statement is not a forward-looking statement.&#160; These forward-looking statements are based on
the Company&#146;s current expectations and are subject to a number of risks,
uncertainties and assumptions. The Company&nbsp;undertakes no obligation to
update any forward-looking statements, whether as a result of new information,
future events or otherwise.&nbsp; Among the important factors that could cause
actual results to differ significantly from those expressed or implied by such
forward-looking statements are risks relating to the successful implementation
of our business and integration strategy relative to our Regentek division; the
continued growth of the bone growth stimulation market; the successful move of
manufacturing operations to our new Mexico facility; our ability to
successfully develop, license or acquire, and timely introduce and market new
products or product enhancements; our dependence on orthopedic professionals,
agents and distributors for marketing our products; our transition to direct
distribution of our products in select foreign countries; our international
operations; the restrictions imposed by the terms of our indebtedness; our
ability to generate cash to service our indebtedness; government regulations;
developing and protecting our intellectual property; and the effects of
healthcare reform, managed care and buying groups on prices of our products.&#160; Other risk factors are detailed in our Annual Report on Form 10-K for the 2003 calendar
year, filed on March 12, 2004 with the Securities and Exchange Commission.</font></p>

<p style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">###</font></p>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="line-height:normal;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<p align="center" style="line-height:normal;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\cmuller\04-10980-1\task189642\10980-1-no.htm',USER='cmuller',CD='Sep 27 21:54 2004' -->


</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>a04-10980_1ex99d3.htm
<DESCRIPTION>EX-99.3
<TEXT>
<html>

<head>



</head>

<body link="blue" vlink="purple">

<div style="font-family:'Times New Roman';">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit
99.3</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="111" height="51" src="g109801moimage002.gif"></font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="100%" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Company
  Investor/ Media Contact:</font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics, Inc.</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mark Francois<br>
  Director of Investor Relations</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(760) 734-4766</font></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">mark.francois@djortho.com</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<h5 align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">FOR IMMEDIATE RELEASE </font></u></b></h5>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">DJ ORTHOPEDICS&#146; BOARD OF DIRECTORS AUTHORIZES STOCK
REPURCHASE PROGRAM</font></b></p>

<p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SAN
DIEGO, CA, September 28, 2004 </font></b><font size="2" style="font-size:10.0pt;">&#150; dj Orthopedics, Inc. (NYSE: DJO), a global medical
device company specializing in rehabilitation and regeneration products for the
non-operative orthopedic and spine markets, </font><font size="2" style="font-size:10.0pt;">announced
today that its board of directors has authorized a program to repurchase up to
$20 million of dj Orthopedics&#146; common stock.&#160;
The shares may be repurchased at times and prices as determined by
management and may be completed through open market or privately negotiated
transactions.&#160; The repurchases will be
made in accordance with applicable state and federal law and in accordance with
the terms and subject to the restrictions of Rule 10b-18 under the Securities
Exchange Act of 1934, as amended.&#160; Shares
will be retired and cancelled upon repurchase.&#160;
As of September 27, 2004, dj Orthopedics had approximately 22.1 million
shares outstanding.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;</font><font size="2" style="font-size:10.0pt;">The first half of 2004 was marked by the
achievement of many important milestones in revenue growth, operating results
and continued strong cash flow,&#148; said Les Cross, president and CEO of dj
Orthopedics.&#160; &#147;With a conviction that dj
Orthopedics will continue to generate strong free cash flow, in concert with a
current share price that is trading well below its recent highs and a low
interest rate environment, a share repurchase program represents a sound and
accretive use of cash.&#148;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics said that it
is in the process of obtaining an amendment to its credit agreement which is
required prior to implementing the stock repurchase program.</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In three separate press releases today, dj Orthopedics also announced
that:</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Company provided an update on its expectations for the third quarter financial
results and Regentek integration.</p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The
Company&#146;s Mexico facility was named as one of <i><font style="font-style:italic;">IndustryWeek&#146;s</font></i>
ten best manufacturing plants in North America.&#160; The release also updated the Company&#146;s progress on its new
manufacturing facility in </p>

<p align="center" style="margin:0in 0in .0001pt .25in;text-align:center;text-autospace:none;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">-more-</font></p>

<p style="margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\vgurram\04-10980-1\task189513\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;">&nbsp;</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="1%" valign="top" style="padding:0in .7pt 0in .7pt;width:1.62%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;text-autospace:none;">&nbsp;</p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.82%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;text-autospace:none;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.56%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mexico.&#160; In the release dj
  Orthopedics announced that it will host an investor day at the new
  manufacturing facility on November 30, 2004.</font></p>
  </td>
 </tr>
 <tr>
  <td width="1%" valign="top" style="padding:0in .7pt 0in .7pt;width:1.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&#149;</font></p>
  </td>
  <td width="1%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:1.82%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;text-autospace:none;">&nbsp;</p>
  </td>
  <td width="96%" valign="top" style="padding:0in .7pt 0in .7pt;width:96.56%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The </font>Company has expanded its
  international strategy with the acquisition of its largest distributor in
  Scandinavia.</p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt .25in;text-autospace:none;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conference Call Information</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics has scheduled an investor conference
call to discuss today&#146;s announcements beginning at 10:00 AM, Pacific Time, 1:00
PM Eastern Time, today, September 28, 2004.&#160;
Individuals interested in listening to the conference call may do so by
dialing (706) 634-0177, using the reservation code 1133883.&#160; A telephone replay will be available for 48
hours following the conclusion of the call by dialing (706) 645-9291 and using
the above reservation code.&#160; The live
conference call also will be available via the Internet at www.djortho.com, and
a recording of the call will be available on the Company&#146;s website.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About dj Orthopedics, Inc.</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dj Orthopedics is a global medical device company
specializing in rehabilitation and regeneration products for the non-operative
orthopedic and spine markets.&#160; The
Company&#146;s broad range of over 600 rehabilitation products, including rigid knee
braces, soft goods and pain management products are used in the prevention of
injury, in the treatment of chronic conditions and for recovery after surgery
or injury.&#160; The Company&#146;s regeneration
products consist of bone growth stimulation devices that are used to treat
nonunion fractures and as an adjunct therapy after spinal fusion surgery.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company sells its products in the United States and in more than 35
other countries through networks of agents, distributors and its direct sales
force that market its products to orthopedic and podiatric surgeons, spine
surgeons, orthopedic and prosthetic centers, third party distributors,
hospitals, surgery centers, physical therapists, athletic trainers and other healthcare
professionals.&#160; For additional
information on the Company, please visit www.djortho.com.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Safe Harbor Statement</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934.&#160; Such
statements relate to, among other things, the Company&#146;s anticipated repurchase
of its common stock and the anticipated effect this may have on the Company&#146;s
earnings and the Company&#146;s future cash flow.&#160;
The words &#147;believe,&#148; &#147;should,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;estimate&#148; and
&#147;anticipate,&#148; variations of such words and similar expressions identify
forward-</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- SEQ.=1,FOLIO='',FILE='C:\jms\vgurram\04-10980-1\task189513\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">looking statements, but their absence does not mean that a statement is
not a forward-looking statement.&#160; Forward-looking
statements are based on the Company&#146;s current expectations and are subject to a
number of risks, uncertainties and assumptions. The Company&nbsp;undertakes no
obligation to update any forward-looking statements, whether as a result of new
information, future events or otherwise.&nbsp; Among the important factors that
could cause actual results to differ significantly from those expressed or
implied by such forward-looking statements are risks relating to the successful
implementation of our business strategy; the continued growth of our markets;
the success of our manufacturing initiatives; product development and/or
product licensing and timely product introductions; our dependence on
orthopedic professionals, agents and distributors for marketing our products;
our transition to direct distribution of our products in select foreign
countries; our international operations; the restrictions imposed by the terms
of our indebtedness; government regulations; developing and protecting our
intellectual property; and the effects of healthcare reform, managed care and
buying groups on prices of our products.&#160;
Other risk factors are detailed in our Annual Report on Form 10-K for the 2003 calendar year, filed on March 12,
2004 with the Securities and Exchange Commission.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

</div>


<!-- SEQ.=1,FOLIO='',FILE='C:\jms\vgurram\04-10980-1\task189513\10980-1-mo.htm',USER='vgram',CD='Sep 28 05:41 2004' -->
</body>

</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g109801mmimage002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109801mmimage002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_VP!#`0H+"PX-#AP0$!P[
M*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SO_P``1"``S`'$#`2(``A$!`Q$!_\0`'``!``("`P$`````````
M``````4'`P0"!@@!_\0`.1```00!`00&"`,)`0```````0`"`P0%$082(3$'
M(E%4<9,3%!4706'1TC*!L2,D,T)#<I&ALN'_Q``:`0$``@,!````````````
M`````0,"!`4&_\0`*A$``@$!!@4#!0````````````$"$0,%$R%!8002%3%1
M<9&Q(D)2H<'_W0`$`"C_V@`,`P$``A$#$0`_`+F1$0$+?VD;1S-;&&C8=)8>
M&LD.@803H2#Q)T\%-+K&0'K?2#C8>;:M=\SO$ZCZ*7RN)9E?5O26)HA7E$FD
M3M-_3X%""014=M3D;T>U.29'=L,8VR\!K97``:^*BO:N1[_:\YWU53M-COPN
M64XJ7/WV/0R+SS[5R/?[7G.^JY,R64D>UC+MMSW$!K6RN))[!Q48NQET.7Y_
MH]"(J.P0N9#:"'%W\AD8#(\QD,>=YKNP@GA\5HWLA<AOV(H,C;="R5S8RZ9Q
M):"=-?R4XFQ@KG;GR*>=*]B_T7GGVKD>_P!KSG?52&`R5]^T6,8^]8<UUN($
M&5Q!&^/FF+L3*Y91BWS]MB]D451Q$]3-6[[[SY8YP0V(ZZ-X@]OPY#Y%2JM.
M"$1$!Q<YK&%[B`UHU)/P"ZQB@_:V2>_<?*,>R0QUJS'E@=IS<[3B3_ZI_)PR
M6,5;@B_B20/8WQ+2`NM[)9K'4=EXX;%AD<]=SVOA)_:%Q<2`&\R>(0AGS9NG
M%'MAF'0%YAK,;`S?>7%NO$C4_-I6:!LD?2$Z&&S.^-M,R3-?(7`DGAPY#FWD
ML>PMJ*PW(3/D:+5JT^1T6O6:WAS'BXK-L_\`O6U>>NGDQ[(&G^W@?^0A"*MV
MK!=M;DP`23:>`!XK:CV9KLR,.(MY!T.3G``C;%O1Q.<-6M>[774\.0.FJY9.
MQ#4Z1IK-@:PQ9$/DX:]4/U*D35-/;6SG\B]HQ\5A]F*4/!]/Q)8UG:>7AIQ6
MM3,]L[24;.*3I]-?5Z(AL/LV[*6+]22R*UJG$]Y8YFK>H=#O.UZO$_-2^`P6
M(&T>)=7S3;).DY8(=""S5Q#N/5_#KQ6C1R(]D[29%\C&6;I;&UF]Q(>\N?H.
MS0?[7'8IA=D+YC(]8;CIO0-)`WGD``#7Y$HJ9"V=JX6C<J4RT\?&9([-,AM;
M<SWZMGU@1Q3VB][/1@.((XZGX%PXJ'O8.I'@O:M')>MB.P()FF$L`<1J"TD\
M1P^2V,268O"[0.?/%ZP88ZS&LD!WM]W7T[=`..G!'LW>CN(1/8=_(.DEZX!&
MC0UHTUU/,E-`N:-K6+RK&/KE7^Z&HW#5:E2K8R]R2L;C=^&**$2.#.6^[4C0
M=G,E9JN+FPVW5+'SN:Y\5V'1S>3@7-((\00I3/4#GLU4OPR1LQ3J\0=8+P&P
MM:.LT]CAQX<RM.7*LS72+5O1-+8GWH&Q@C^5KF@?IK^:42$;6<XNK^UUV>B^
M2ZD1%LGBPB(@"UACZ0M&T*<`L'^KZ,;_`/GFME$!@;%6J-EECBCB!U?(YC0-
M>TG3FH+8:-QPDMQXT=<LR2ZGQT_4%?6;-WH(KE*#)-;1N2.>_>C)E:'?B:#K
MIQ[=%/5:T5.K%6@9N11-#6CL`0@KC.=&^8R6;N7H;-)L<\SGM#WN!`)^/56A
M[J<[WJAYC_M5MHJ\.)U8WMQ,8J*:RV*D]U.=[U0\Q_VI[J<[WJAYC_M5MHF'
M$RZOQ7E>Q4GNISO>J'F/^U/=3G>]4/,?]JMM$PXCJ_%>5[%2>ZG.]ZH>8_[5
MMXKHTS5'+TKDMFD8Z]B.1P:]^I#7`G3J_)6@B8<2)7MQ,DTVO8(B*PY01$0!
8$1`$1$`1$0!$1`$1$`1$0!$1`$1$!__9
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g109801moimage002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109801moimage002.gif
M1TE&.#EA;P`S`'<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"P`
M````;P`S`(4`,P``,S,S```S`#,S,P`S,S,S9C,S9F9F``!F,S-F,V9F9C-F
M9F9F9IEFF69FF9F9``"9`#.9,S.9,V:99F:99IF9F6:9F9F9S)F9S,S,``#,
M`#/,,S/,,V;,9F;,9IG,F9G,F<S,S)G,S,S,S/_,_\S,____9F;_9IG_F9G_
MF<S_S,S_S/___\S___\!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!`@,!
M`@,!`@,!`@,!`@,!`@,!`@,!`@,&_T"7<$@L&H_(I'+);#J?T*AT2JU:K]BL
M=LOM<DT@1L%++C,O`4*!<#"[W\,2*%`(,.!XMR5]R?N]#P,!(T4L!@E"'AX?
M)XJ,CHV+D8^2D):5F)2:DYP>*T(/B%X.:T8'!`%]$*L1JQ"MK*ZPK[*UL;>T
MN+.[M80/!`P"7@=U1G4#0J[*JQJNS<S+T-(0S\O5U]'4KBHN"6)C774&1Q9#
MM!*TK:WHZN?I[NWK'"`N[!#V[?CNGQD"#`1>`@RXH\29P6G8$!Z$L(&0BX3:
M%$+CYF)$GRXFU%Q,\BY6.X^YWO%J)R1>K8\B(3@L$R+-2B36LE53-C.;LHK1
M:DY31K',!?]43.#=$VJOJ#L)+CZ\<W$BEM%U1"%\XG*!P0$&(QC0*0+BP=1D
M$B.*A=B,@XL-RI!2H+F0+(2>6"X4$$`G`-T";8:@0M7"'$B3@%.VHA?/@PL.
M@1._>VF%`IT,0Q@(HA#Y0<L"&/S*W&P3`@)NTNAUWKD0;I4]!$P420.92,94
MYJ":1`?REH99+E;<ZNL*G;YUM]^A^UIE!9T'13#4(>YBS@#58,6N^L3"10H$
MSR8(N3TD@@IZ)E*,>)8;P503;"&0&!*"K>DIIP(8<0RPR"]PR5`B'4'+.BP/
M2!F&U&&,6*?(.LTUIX$0'<BR8`H(MM<.8U*,0!=!1!PP`'Y#*+#_E68WN>`*
M`BD\Y,H&0J"3VRJ4T;:*62XTB`"*39''`@*NA"`B3U=H14!K1!10P`+&`$.$
M2(8A-M0'+GA`BV&ZN0B!:/8P&>4]S=%"#SY)0L6<%`4(4MUJ!2!7!%T5'"E-
M=,T8UJ!G*)PEW2?8K?*9G,V@^"8$8#W#Y)O-O!>%&O6YALI&0HS@DIKGK!@+
M/0VV`M8N^;DR*00"OFC=+?1P$`N%4=1EA'/0#7&!($4LTX$+*$2$0'75X&30
M@JW>Q)^=)3YCF%(ASO+6%6IP"(H:1HA1:*7H[.K.I4V"%&`Z"SK9WXX1K.H!
M5`/N<X6H1=0AK`O$Y*59GJPJD^DJ2-'V_PP"JZ+EBG:`\DE";\UJ<X*<$UVQ
MP!HE$&&LN'K9D>I'T46`TW\FOL-DLJL8]HRD'^"F6W\0+G:%A1^ZX%@==U`V
MA$"([IB6@OLM0XAT$*SZ70JKK!>1P2:H0)M9*$1@%LO1"!J%`X3&)X(!/0\Q
M`BJ,$?7)"D]I\-0J)7KZBM+N?)""/=0<[;117T[QP#$'?!*"D(BB(4RJI'F6
MWEAMI6WV03BFK7,9#1!+MF!T*V9WW7B#:D8"`8C":$Z<Q03XX((7_C89:YAY
MI&S"I?3;4+,Y+GGD69=A@B`A[]CV,ILKT_F(V7QN9^BD_YJ'"&N4^L?J5VPM
M'^NP6U$'D;'7OCY$!0!@Z()`>MON^RGX_0*P[\0/X=@`A)2`:O',$[&`70$`
>8$!?S5=?T0,5]&[]]MQW[_WWX(<O_OCDEQ][$``[
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g109801noimage002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g109801noimage002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#__@`<4V]F='=A<F4Z($UI8W)O<V]F="!/
M9F9I8V7_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-#AT5%A$8(Q\E)"(?(B$F
M*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_VP!#`0H+"PX-#AP0$!P[
M*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SO_P``1"``O`&D#`2(``A$!`Q$!_\0`'````@(#`0$`````````
M``````8$!0,'"`(!_\0`.A```0,#``4*`P4)`````````0(#!``%$082(3%1
M$Q070515@9*3T2(R<2,U87.R!Q46,T*"D;'!_\0`&@$!``(#`0``````````
M``````$#`@0&!?_$`"T1``(``P0)`P4````````````!`@,1!!(QH044(5%2
M87&1X1,502(R,U/1_]T`!``H_]H`#`,!``(1`Q$`/P#<U%%1I=PA0`DRY;+&
MMNY183G_`#0%;'O[[VDJK,NWEG4;+BG%.`Y3U$`<:N%.MI7J*<2%8UM4J&<<
M?I2W9%HG:7WF>A:5MMH;90M)R",9.#X5FO$.URH5SN\=3;TE,)QDN(<U@D:I
MV8!P#0F!7HDMY=\ZC=H:\XHYU&[0UYQ7.@&RC%4^KR.C]C7[,O)T7SJ-VAKS
MBCG4;M#7G%<Z8J2JWR$VU%Q4D".XZ6DJUMI4!D[/&GJ\B'H2%8S,O)T%SJ-V
MAKSBCG4;M#7G%:/OT.!%MEG<BQ2P]*CEY[+A5GXL#?\`0GQJDQ1S*?!C+T-#
M'#>4>7DZ+YU&[0UYQ63E$%03KIUB,@9VD<:YP(V&M[0+)&<D0;N5N<LB,A(3
MGX?EQ_VLX([QHV^P*R*%WJUY%W11169YA'G2DP8#\M8REEM2R..!FJ/16&F5
M;C>K@E+TN:2M2UC.HC.`D9W"KNXPQ<+;(AE6J'VU(SPR*7+>G2)BQ_N5-M2T
M\TVIM,M3HY/&W!`&W-"'B9-"8[3MHFOEI(;ERG"$`8&KN`QPWU`M;:%:/:3R
MVD)0V^M\(2D8`"4G&!XU:V-$NS:)K1,BB,J*RM7\P**CM).S=42UQS'_`&:O
M9'Q.Q'G%?W`G_6*AX&<G\D/4UA8;4U<5R7Y:U(APF2\^4?,H=21P).RI#L.%
M/T:DW6/#$)R'(0VI*'%*2XA6[YOZ@>NH]EN;$.//@RPYS:>R&UK:`*FR#E*L
M'>,[Q7V=<V!9V[/;PYS8.EYYUP!*GEXP-@W`#<,UK;*'<1*8YFRN*Z4^?YV+
M:9'T;M;,!R7;GUN3(/*J;;?/V2CG55MWD[/P&-U>;\_"9T8L\%J`I"WF5R4?
M;D\F5*QG=\60GPJGOUR;NURYPRVMME#+;3:%XR`E('5XU-N=VM<UZV/I;DE4
M9EEIUH@!*4HWZO'/ABIKB5*5$KD456\<7SV9Y#%,B6B7I-#L,F*M]QN$AE;P
M=*1'*6RK8!O/6<\:5X%MC,V5^]3D%YI#P8CL!12'7,9)41MU0.&^I,72*-_%
M4^[R6WDHEH>2C4`*V]<82=^#@5'CW*"]8C9YBI#+;4DOL/-H"SM&"E0R/KFC
M:9C!+FRTH=M/IKG6F6!\O=OC-VFV76*SS=,Y#@6P%%02I"L923MP:W=;?NN)
M^0C](K15YNJ;B8[+#2F8<-KDH[:CE6-Y4K\2=IK>MM^ZXGY"/TBK)>+/,TLH
ME*EWL:OQD2J***M.?"O#J^2:6X4E6JDG"1DG'"O=%`*EVOK%ZT6Y.!ME7`\B
MA@D:Z3G"L@;L`&F!NWLIM2+<XG79#(94-VL,8-96XD9IY3S<=I#JOF6E`"C]
M36:@54ZBWT?:+]UI]5?O1T?:+]UI]5?O3)1475N-G6[1QONQ;Z/M%^ZT^JOW
MHZ/M%^ZT^JOWIDHI=6X:W:.-]V+?1]HOW6GU5^]'1]HOW6GU5^],E%+JW#6[
M1QONQ;Z/M%^ZT^JOWIA:;0RTAIL80A(2D<`*]T422P*XYTR9]\3?5A1114E1
"_]D_
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
